agilon health, inc. (AGL)
NYSE: AGL · Real-Time Price · USD
56.56
+28.71 (103.07%)
May 7, 2026, 12:15 PM EDT - Market open
agilon health Stock Forecast
Stock Price Forecast
The 12 analysts that cover agilon health stock have a consensus rating of "Buy" and an average price target of $51.19, which forecasts a -9.49% decrease in the stock price over the next year. The lowest target is $12.5 and the highest is $187.5.
Price Target: $51.19 (-9.49%)
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for agilon health stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Dec '25 | Jan '26 | Feb '26 | Mar '26 | Apr '26 | May '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 1 | 1 | 1 | 1 | 1 | 3 |
| Buy | 3 | 3 | 2 | 2 | 2 | 2 |
| Hold | 13 | 13 | 10 | 10 | 9 | 6 |
| Sell | 1 | 1 | 1 | 1 | 1 | 2 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 18 | 18 | 14 | 14 | 13 | 13 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Evercore ISI Group | Evercore ISI Group | Hold Maintains $16 → $32 | Hold | Maintains | $16 → $32 | -43.42% | May 7, 2026 |
| Jefferies | Jefferies | Hold → Strong Buy Upgrades $28 → $48 | Hold → Strong Buy | Upgrades | $28 → $48 | -15.13% | May 7, 2026 |
| Baird | Baird | Hold Maintains $20 → $35 | Hold | Maintains | $20 → $35 | -38.11% | May 7, 2026 |
| Deutsche Bank | Deutsche Bank | Hold → Strong Buy Upgrades $33 → $49 | Hold → Strong Buy | Upgrades | $33 → $49 | -13.36% | May 7, 2026 |
| JP Morgan | JP Morgan | Hold → Sell Downgrades $21 | Hold → Sell | Downgrades | $21 | -62.87% | May 4, 2026 |
Financial Forecast
Revenue This Year
5.51B
from 5.93B
Decreased by -7.14%
Revenue Next Year
5.76B
from 5.51B
Increased by 4.47%
EPS This Year
-5.97
from -23.63
EPS Next Year
-4.65
from -5.97
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 |
|---|---|---|---|---|---|---|
| High | 5.8B | 6.4B | ||||
| Avg | 5.5B | 5.8B | ||||
| Low | 5.3B | 5.1B |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 |
|---|---|---|---|---|---|---|
| High | -2.7% | 15.4% | ||||
| Avg | -7.1% | 4.5% | ||||
| Low | -10.6% | -7.6% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | -3.82 | -1.35 | |||
| Avg | -5.97 | -4.65 | |||
| Low | -10.22 | -7.21 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | - | - | |||
| Avg | - | - | |||
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data sources.